James Groves
Nessuna posizione attualmente
Profilo
James Groves served as Director at Caristo Diagnostics Ltd.
from 2018 to 2022.
Prior to that, he worked as Principal Licensing & Ventures Manager at Oxford University Innovation Ltd.
Mr. Groves received his graduate degree from the University of Oxford in 2006 and his undergraduate degree from The University of Nottingham in 2005.
Precedenti posizioni note di James Groves
| Società | Posizione | Fine |
|---|---|---|
Caristo Diagnostics Ltd.
 Caristo Diagnostics Ltd. Medical SpecialtiesHealth Technology Caristo Diagnostics Ltd. engages in the development of cardiovascular diagnostic tools. The company was founded by Charalambos Antoniades on June 22, 2018 and is headquartered in Oxford, the United Kingdom. | Direttore/Membro del Consiglio | 01/01/2022 |
Oxford University Innovation Ltd.
 Oxford University Innovation Ltd. Investment ManagersFinance Oxford University Innovation Ltd (Oxford University Innovation) is a venture capital subsidiary of University of Oxford founded in 1987 and spun out in 2010. The firm is headquartered in London, United Kingdom. | Investitore di Private Equity | - |
Formazione di James Groves
| University of Oxford | Graduate Degree |
| The University of Nottingham | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Oxford University Innovation Ltd.
Oxford University Innovation Ltd. Investment ManagersFinance Oxford University Innovation Ltd (Oxford University Innovation) is a venture capital subsidiary of University of Oxford founded in 1987 and spun out in 2010. The firm is headquartered in London, United Kingdom. | Finance |
Caristo Diagnostics Ltd.
Caristo Diagnostics Ltd. Medical SpecialtiesHealth Technology Caristo Diagnostics Ltd. engages in the development of cardiovascular diagnostic tools. The company was founded by Charalambos Antoniades on June 22, 2018 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- James Groves
